National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States.
ACS Chem Biol. 2022 Feb 18;17(2):322-330. doi: 10.1021/acschembio.1c00760. Epub 2022 Feb 4.
Cellular thermal shift assay (CETSA) is a valuable method to confirm target engagement within a complex cellular environment, by detecting changes in a protein's thermal stability upon ligand binding. The classical CETSA method measures changes in the thermal stability of endogenous proteins using immunoblotting, which is low-throughput and laborious. Reverse-phase protein arrays (RPPAs) have been demonstrated as a detection modality for CETSA; however, the reported procedure requires manual processing steps that limit throughput and preclude screening applications. We developed a high-throughput CETSA using an acoustic RPPA (HT-CETSA-aRPPA) protocol that is compatible with 96- and 384-well microplates from start-to-finish, using low speed centrifugation to remove thermally destabilized proteins. The utility of HT-CETSA-aRPPA for guiding structure-activity relationship studies was demonstrated for inhibitors of lactate dehydrogenase A. Additionally, a collection of kinase inhibitors was screened to identify compounds that engage MEK1, a clinically relevant kinase target.
细胞热转移分析(CETSA)是一种在复杂的细胞环境中确认靶标结合的有价值的方法,通过检测配体结合后蛋白质热稳定性的变化来实现。经典的 CETSA 方法使用免疫印迹法测量内源性蛋白质热稳定性的变化,这种方法通量低且繁琐。反相蛋白阵列(RPPA)已被证明是 CETSA 的一种检测方式;然而,所报道的方法需要手动处理步骤,限制了通量并排除了筛选应用。我们开发了一种使用声控 RPPA(HT-CETSA-aRPPA)协议的高通量 CETSA,该协议从头到尾都与 96 孔和 384 孔微孔板兼容,使用低速离心去除热不稳定的蛋白质。HT-CETSA-aRPPA 用于指导乳酸脱氢酶 A 抑制剂的结构-活性关系研究的实用性得到了证明。此外,还筛选了一组激酶抑制剂,以鉴定与 MEK1(一种临床相关的激酶靶标)结合的化合物。